Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Role of Metabolomics in Ovarian Cancer Diagnosis
Asia Saorin, Emanuela Di Gregorio, Gianmaria Miolo, et al.
Metabolites (2020) Vol. 10, Iss. 10, pp. 419-419
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

To metabolomics and beyond: a technological portfolio to investigate cancer metabolism
Federica Danzi, Raffaella Pacchiana, Andrea Mafficini, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 107
Designed Concave Octahedron Heterostructures Decode Distinct Metabolic Patterns of Epithelial Ovarian Tumors
Congcong Pei, You Wang, Yajie Ding, et al.
Advanced Materials (2023) Vol. 35, Iss. 18
Closed Access | Times Cited: 39
Biomarkers in Ovarian Cancer: Towards Personalized Medicine
Carlos López-Portugués, María Montes‐Bayón, Paula Díez
Proteomes (2024) Vol. 12, Iss. 1, pp. 8-8
Open Access | Times Cited: 9
Metabolomics in oncology
Gurparsad Singh Suri, Gurleen Kaur, Giuseppina M. Carbone, et al.
Cancer Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 16
Recent Progress in Intelligent Wearable Sensors for Health Monitoring and Wound Healing Based on Biofluids
Siyang Cheng, Zhen Gu, Liping Zhou, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 38
In Silico Collision Cross Section Calculations to Aid Metabolite Annotation
Susanta Das, Kiyoto Aramis Tanemura, Laleh Dinpazhoh, et al.
Journal of the American Society for Mass Spectrometry (2022) Vol. 33, Iss. 5, pp. 750-759
Open Access | Times Cited: 19
Metabolomics of ischemic stroke: insights into risk prediction and mechanisms
Ruijie Zhang, Jiajia Meng, Xiaojie Wang, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 7, pp. 2163-2180
Closed Access | Times Cited: 19
Mutational profiling of mitochondrial DNA reveals an epithelial ovarian cancer‐specific evolutionary pattern contributing to high oxidative metabolism
Fanfan Xie, Wenjie Guo, Xingguo Wang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women
Samyukta Sah, Olatomiwa O. Bifarin, Samuel G. Moore, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 5, pp. 681-693
Open Access | Times Cited: 4
The Role of Albumin-To-Fibrinogen and Fibrinogen-To-Prealbumin Ratios in the Development of Ovarian Carcinoma
Valeria Racheva, I. Dekova, Zornitsa Gorcheva, et al.
Acta Medica Bulgarica (2025) Vol. 52, Iss. 1, pp. 41-47
Open Access
Precision medicine approaches in metabolic disorders and target organ damage: where are we now, and where are we going?
Amedeo Lonardo, Christopher D. Byrne, Giovanni Targher
Metabolism and Target Organ Damage (2021)
Open Access | Times Cited: 26
Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients
Tong Qu, Shaopeng Zhang, Shaokang Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer
Eiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.
Toxins (2021) Vol. 13, Iss. 7, pp. 461-461
Open Access | Times Cited: 22
Microbiome and Development of Ovarian Cancer
Aditi Dhingra, Divyani Sharma, Anuj Kumar, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 11, pp. 1073-1090
Closed Access | Times Cited: 15
Prediction and evaluation of the effect of pre-centrifugation sample management on the measurable untargeted LC-MS plasma metabolome
Rui Zheng, Carl Brunius, Lin Shi, et al.
Analytica Chimica Acta (2021) Vol. 1182, pp. 338968-338968
Open Access | Times Cited: 14
The Prognosis Predictive Score around Neo Adjuvant Chemotherapy (PPSN) Improves Diagnostic Efficacy in Predicting the Prognosis of Epithelial Ovarian Cancer Patients
Naoki Kawahara, Shoichiro Yamanaka, Sumire Sugimoto, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5062-5062
Open Access | Times Cited: 5
The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer
Naoki Kawahara, Ryuji Kawaguchi, Keita Waki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study
Shaoxuan Liu, Dan‐Ni Ding, Fang-Yuan Liu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
MR Relaxometry for Discriminating Malignant Ovarian Cystic Tumors: A Prospective Multicenter Cohort Study
Naoki Kawahara, Hiroshi Kobayashi, Tomoka Maehana, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1069-1069
Open Access | Times Cited: 1
Metabolomic Analysis of Actinic Keratosis and SCC Suggests a Grade-Independent Model of Squamous Cancerization
Valeria Righi, Camilla Reggiani, Elisabetta Tarentini, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5560-5560
Open Access | Times Cited: 10
Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells
Ji Hee Ha, Muralidharan Jayaraman, Revathy Nadhan, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1927-1927
Open Access | Times Cited: 10
Sensor detection in gynaecological medicine
Michael Thompson, Soha Ahmadi, Katharina Davoudian, et al.
Sensors & Diagnostics (2022) Vol. 1, Iss. 5, pp. 877-901
Open Access | Times Cited: 7
Exploring Metabolic Signatures of Ex Vivo Tumor Tissue Cultures for Prediction of Chemosensitivity in Ovarian Cancer
Rita Mendes, Gonçalo Graça, Fernanda Silva, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4460-4460
Open Access | Times Cited: 7
Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations
Mitchell Acland, Noor A. Lokman, Clifford Young, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2763-2763
Open Access | Times Cited: 6
The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma
Naoki Kawahara, Ryuji Kawaguchi, Tomoka Maehana, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2683-2683
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top